Sökresultat

Congratulations to Göran Jönsson who receives this year's Göran Gustafsson Prize in medicine. The prize is awarded by the Royal Academy of Sciences and is awarded to younger researchers who have achieved great success in their field. Göran Jönsson, professor in molecular oncology at Lund University, receives the award "for his pioneering work in describing the genetic and molecular landscape, as w

https://www.lucc.lu.se/article/goran-jonsson-receives-goran-gustafssons-prize-medicine-groundbreaking-research-immunotherapy-cancer - 2025-12-29

Alexander Pietras, Associate Professor at Lund University, have been awarded an European Research Council Consolidator Grant (ERC-CoG) for the project - RESISTANCEPROGRAMS. The research group will explore and exploite the post-radiotherapy brain microenvironment for therapeutic opportunities in malignant brain tumors. Glioblastoma multiforme (GBM), the deadliest form of brain tumor, occurs in both

https://www.lucc.lu.se/article/euroupean-research-council-consolidator-grant-alexander-pietras - 2025-12-29

In a recent study from Lund University in Sweden, researchers discovered that metabolic changes affect how blood cells are formed during embryonic development. They found a previously unknown metabolic switch with a key role in how different types of blood cells develop. This means blood cell formation can be directed towards producing natural killer cells in the laboratory to ultimately be used i

https://www.lucc.lu.se/article/metabolism-found-regulate-production-killer-cells - 2025-12-29

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionised areas of cancer care. However, there are still significant challenges in the identification of cancer cell surface proteins as targets for immunotherapies. A research group

https://www.lucc.lu.se/article/new-precision-technology-immunotherapy - 2025-12-29

Smokers have a lower risk of developing prostate cancer, but a higher risk of dying from the disease, according to a large population study led by Lund University in Sweden. The researchers followed more than 350 000 people over several decades, and the results are now published in European Urology. It is well known that smokers have an increased risk of developing various cancers, but there have

https://www.lucc.lu.se/article/smoking-worsens-prognosis-men-prostate-cancer - 2025-12-29

Skåne University Hospital Cancer Centre (SUHCC) has been accredited as Comprehensive Cancer Centre (CCC) by the Organisation of European Cancer Institutes (OECI). The accreditation as Comprehensive Cancer Centre means that an organisation has been approved according to the highly set quality criteria of the Organisation of European Cancer Institutes (OECI). Skåne University Hospital Cancer Centre

https://www.lucc.lu.se/article/skane-university-hospital-cancer-centre-accredited-comprehensive-cancer-centre - 2025-12-29

By using cells isolated from cancer patients and mixing them with a new technology called “OssiGel”, it is possible to engineer human mini-bones. These miniaturized organs consist of mature bone and marrow tissue and can be used as model to study the disease mechanisms behind cancers that arise in bone marrow or spread to the bones, and offer the personalized testing of new drugs. Paul Bourgine is

https://www.lucc.lu.se/article/miniature-bones-research-model-cancer - 2025-12-29

The environment in which breast cancer arises –the interplay between the patient’s BMI, tumour size and cancer-specific proteins –is of importance for the prognosis. This is shown in a study from Lund University in Sweden. The knowledge could further enhance precision medicine in breast cancer. Major advances in diagnostics and treatment have improved survival rates among breast cancer patients in

https://www.lucc.lu.se/article/tumour-environment-can-affect-breast-cancer-prognosis - 2025-12-29

Göran Jönsson, professor of molecular oncology, receives SEK 31 million from the Knut and Alice Wallenberg Foundation to enhance the effect of immunotherapy in the treatment of cancer patients. About 30 per cent of patients with metastatic melanoma benefit from immunotherapy. At the same time, this means that 70 per cent of all melanoma patients still have no effective treatment option. Göran Jöns

https://www.lucc.lu.se/article/sek-31-million-enhance-effect-immunotherapy-treatment-cancer-patients - 2025-12-29

Researchers at Lund University in Sweden have identified one of the reasons why the childhood cancer neuroblastoma becomes resistant to chemotherapy. The findings are significant for how future treatments should be designed. The results have been published in Science Advances. Neuroblastoma is an aggressive cancer of the sympathetic nervous system, especially of the adrenal gland. Despite intense

https://www.lucc.lu.se/article/altered-cell-behaviour-behind-resistance-neuroblastoma - 2025-12-29

Stem cells programmed to produce insulin in people with type 1 diabetes or to repair the heart muscle after a heart attack. Gene and cell therapies that improve cancer treatments. These new and innovative therapies have the potential to cure, alleviate and treat diseases where traditional medicines are currently insufficient. The monk Gregor Mendel set more in motion than he could have imagined wh

https://www.lucc.lu.se/article/advanced-treatments-future-are-soon-here - 2025-12-29

By reprogramming tumour cells to become the body’s defenders, Filipe Pereira and his colleagues hope to improve current cancer treatments. Right now, some of the immune system’s most important players, the dendritic cells, are patrolling your body in search of foreign substances. If they find something suspicious, they break it down into smaller pieces, called antigens, which are presented to the

https://www.lucc.lu.se/article/reprogramming-cancer-cells-immune-defenders - 2025-12-29

Researchers at Lund University have generated human mini bones in the lab which mirror the composition and function of human bone. The results published in Science Translational Medicine detail this step toward the future development of patient-tailored, personalized models of bone cancers and tumors. On average, the adult body consists of 206 bones. Housed in the center of each, is bone marrow, t

https://www.lucc.lu.se/article/toward-personalized-approach-study-and-treatment-bone-cancers - 2025-12-29

Congratulations to Jessica Wihl with the PhD thesis entitled "Multidisciplinary Team Meetings in Cancer Care: Case Discussions, Patient Selection, Leadership" who was awarded with the best cancer PhD thesis of year 2022. The award was presented 4 May 2023 at Lund University Cancer Centre internal one-day meeting with presentation of the thesis by the winner. The prize sum was 80,000 SEK and sponso

https://www.lucc.lu.se/article/best-phd-thesis-award-cancer-2022-lund-university - 2025-12-29

Christelle Prinz, Professor of Solid State Physics at Lund University, has been awarded an ERC Proof of Concept Grant for her research into creating cost-effective biosensor diagnostics for the early detection of ovarian cancer. What is your research project about? The project is a collaboration work with Dr. Jae Yen Shin, a former colleague and entrepreneur. We will use my lab's micro- and nanote

https://www.lucc.lu.se/article/erc-grant-research-early-detection-ovarian-cancer - 2025-12-29

What happens when you mix a group of tumor biology researchers with software developers and AI researchers? Hopefully, with the help of AI, they can connect a multitude of data that leads to new treatments for kidney cancer – that's at least what the researchers in the EU-project KATY envision. But first, they need to find a common language that all professional groups understand. – It's a challen

https://www.lucc.lu.se/article/kicking-kidney-cancer - 2025-12-29

Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s conventional double reading by radiologists and can reduce heavy workloads for doctors. This has now been shown in an interim analysis of a prospective, randomised controlled trial, which addressed the clinical safety of using AI in mammography screening. The trial, led by researchers from Lund Univers

https://www.lucc.lu.se/article/ai-supported-mammography-screening-found-be-safe - 2025-12-29

BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer. A multi-year Swedish study now reveals that the proportion of women with genetically confirmed hereditary breast cancer doubled by including all genes in the

https://www.lucc.lu.se/article/breast-cancer-study-altered-guidelines-sweden - 2025-12-29

UroCan – LUCC: translational cancer research network explains their research in a film. Film on YouTube Bladder cancer research group at Lund University Cancer Centre explains the importance of research done in the past years. What is the future of bladder cancer diagnosis and treatment? Did you know you can directly contact the research centre if you experience bladder cancer symptoms? Get to kno

https://www.lucc.lu.se/article/urinary-bladder-cancer-research - 2025-12-29

The government has appointed Professor Mef Nilbert as a special investigator with the task of submitting proposals for an updated national cancer strategy. The updated strategy is the next step in developing the existing strategy that was presented in 2009, but is adapted to address the major developments that have taken place in cancer care since then. The update is made to ensure that Sweden has

https://www.lucc.lu.se/article/mef-nilbert-leads-update-new-swedish-cancer-strategy - 2025-12-29